Risk Assessment and Control of N -Nitrosamines in Antibody–Drug Conjugates: Current Industry Practices
Organic Process Research & Development · 16.08.2024 · 28 (8) · 3078-3084
DOI: 10.1021/acs.oprd.4c00254 ↗Kurz gefasst
Fachartikel in der Zeitschrift Organic Process Research & Development, online erschienen am 30.07.2024. Verfasst von Paul G. Bulger und 12 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Bulger, P. G., Jones, M. T., Ford, J. G., Schrier, K., Cole, K. P., Bernardoni, F., Dirat, O., Zhang, Q., Chahrour, O., Miller, J., Bonaga, L., Parsons, A. T., & Yang, L. (2024). Risk Assessment and Control of N -Nitrosamines in Antibody–Drug Conjugates: Current Industry Practices. Organic Process Research & Development, 28(8), 3078-3084. https://doi.org/10.1021/acs.oprd.4c00254
Vancouver
Bulger PG, Jones MT, Ford JG, Schrier K, Cole KP, Bernardoni F, et al. Risk Assessment and Control of N -Nitrosamines in Antibody–Drug Conjugates: Current Industry Practices. Organic Process Research & Development. 2024;28(8):3078-3084. doi:10.1021/acs.oprd.4c00254
BibTeX
@article{Bulger2024,
author = {Bulger, Paul G. and Jones, Michael T. and Ford, J. Gair and Schrier, Kate and Cole, Kevin P. and Bernardoni, Frank and Dirat, Olivier and Zhang, Qunying and Chahrour, Osama and Miller, Joy and Bonaga, Llorente and Parsons, Andrew T. and Yang, Lan},
title = {Risk Assessment and Control of N -Nitrosamines in Antibody–Drug Conjugates: Current Industry Practices},
journal = {Organic Process Research & Development},
year = {2024},
volume = {28},
number = {8},
pages = {3078--3084},
doi = {10.1021/acs.oprd.4c00254}
}
EUVIMED